Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries

Health Economics (United Kingdom)

Volumn 25, Issue , 2016, Pages 95-115

  Vassall, Anna ^a   Mangham Jefferies, Lindsay ^a   Gomez, Gabriela B ^a,b,c   Pitt, Catherine ^a   Foster, Nicola ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

demand; economic evaluation; health system; health technology assessment

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL RESEARCH; CONCEPTUAL FRAMEWORK; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; ECONOMIC EVALUATION; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE QUALITY; HEALTH IMPACT ASSESSMENT; LOWEST INCOME GROUP; MALARIA CONTROL; MALARIA RAPID TEST; MODEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUBERCULOSIS CONTROL; TUBERCULOSIS RAPID TEST; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMIC MODEL; ECONOMICS; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH SERVICE; HEALTH SERVICES RESEARCH; HUMAN; PROCEDURES;

COST-BENEFIT ANALYSIS; DECISION MAKING; DEVELOPING COUNTRIES; ECONOMICS, MEDICAL; HEALTH CARE COSTS; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SERVICES RESEARCH; HUMANS; MODELS, ECONOMIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84956577534     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.3306     Document Type: Article

References (71)

1. Abimbola TO, Marston BJ, Date AA, Blandford JM, Sangrujee N, Wiktor SZ,. 2012. Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy. J Acquir Immune Defic Syndr 60: e1-7.
2. Achonduh OA, Mbacham WF, Mangham-Jefferies L, Cundill B, Chandler C, Pamen-Ngako J, Lele AK, Ndong IC, Ndive SN, Ambebila JN, Orang-Ojong BB, Metoh TN, Akindeh-Nji M, Wiseman V,. 2014. Designing and implementing interventions to change clinicians' practice in the management of uncomplicated malaria: lessons from Cameroon. Malar J 13: 204.
3. Andrews JR, Lawn SD, Rusu C, Wood R, Noubary F, Bender MA, Horsburgh CR, Losina E, Freedberg KA, Walensky RP,. 2012. The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS 26: 987-995. DOI: 10.1097/QAD.0b013e3283522d47.
4. Ansah EK, Epokor M, Whitty CJ, Yeung S, Hansen KS,. 2013. Cost-effectiveness analysis of introducing RDTs for malaria diagnosis as compared to microscopy and presumptive diagnosis in central and peripheral public health facilities in Ghana. Am J Trop Med Hyg 89: 724-36.
5. Atun R, De Jongh T, Secci F, Ohiri K, Adeyi O,. 2010a. Integration of targeted health interventions into health systems: a conceptual framework for analysis. Health Policy Plan 25: 104-11.
6. Atun R, De Jongh T, Secci F, Ohiri K, Adeyi O,. 2010b. A systematic review of the evidence on integration of targeted health interventions into health systems. Health Policy Plan 25: 1-14.
7. Barton GR, Fairall L, Bachmann MO, Uebel K, Timmerman V, Lombard C, Zwarenstein M,. 2013. Cost-effectiveness of nurse-led versus doctor-led antiretroviral treatment in South Africa: pragmatic cluster randomised trial. Trop Med Int Health 18: 769-77.
8. Basu S, Modrek S, Bendavid E,. 2014. Comparing decisions for malaria testing and presumptive treatment: a net health benefit analysis. Med Decis Making 34: 996-1005.
9. Batwala V, Magnussen P, Hansen KS, Nuwaha F,. 2011. Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar J 10: 372.
10. Bisoffi Z, Sirima SB, Meheus F, Lodesani C, Gobbi F, Angheben A, Tinto H, Neya B, Van Den Ende K, Romeo A, Van Den Ende J,. 2011. Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso. Malar J 10: 226.
11. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD,. 2011. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495-505.
12. Bualombai P, Prajakwong S, Aussawatheerakul N, Congpoung K, Sudathip S, Thimasarn K, Sirichaisinthop J, Indaratna K, Kidson C, Srisuphanand M,. 2003. Determining cost-effectiveness and cost component of three malaria diagnostic models being used in remote non-microscope areas. Southeast Asian J Trop Med Public Health 34: 322-33.
13. Chanda P, Castillo-Riquelme M, Masiye F,. 2009. Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia. Cost Eff Resour Alloc 7: 5.
14. Chanda P, Hamainza B, Moonga HB, Chalwe V, Banda P, Pagnoni F,. 2011. Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management. Malar J 10: 159.
15. Chen IT, Aung T, Thant HN, Sudhinaraset M, Kahn JG,. 2015. Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar. Malar J 14: 55.
16. Churchyard GJ, Stevens WS, Mametja LD, Mccarthy KM, Chihota V, Nicol MP, Erasmus LK, Ndjeka NO, Mvusi L, Vassall A, Sinanovic E, Cox HS, Dye C, Grant AD, Fielding KL,. 2015. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. Lancet Glob Health 3: e450-7.
17. De Oliveira MR, De Castro Gomes A, Toscano CM,. 2010. Cost effectiveness of OptiMal(R) rapid diagnostic test for malaria in remote areas of the Amazon Region, Brazil. Malar J 9: 277.
18. De Oliveira MR, Giozza SP, Peixoto HM, Romero GA,. 2012. Cost-effectiveness of diagnostic for malaria in Extra-Amazon Region, Brazil. Malar J 11: 390.
19. De Silva MJ, Breuer E, Lee L, Asher L, Chowdhary N, Lund C, Patel V,. 2014. Theory of change: a theory-driven approach to enhance the Medical Research Council's framework for complex interventions. Trials 15: 267.
20. Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J,. 2009. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health 12: 409-18.
21. Drummond M, Manca A, Sculpher M,. 2005. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care 21: 165-71.
22. Faye A, Ndiaye P, Diagne-Camara M, Badiane O, Wone I, Diongue M, Seck I, Dia AT, Dia AL,. 2010. [Economic evaluation of rapid diagnostic tests in malaria treatment]. Sante Publique 22: 617-23.
23. Foster NSM, Cleary S, Fielding K, McCarthy K, Grant A, Churchyard G, Cunnama L, Sinanovic E, Vassall A,. 2015. Exploring the impact of health systems factors in decision-making involving TB diagnostics in South Africa. IHEA, Milan.
24. Gheorghe A, Kyte D, Calvert M,. 2014. The need for increased harmonisation of clinical trials and economic evaluations. Expert Rev Pharmacoecon Outcomes Res 14: 171-3.
25. Gomes M, Grieve R, Nixon R, Edmunds WJ,. 2012. Statistical methods for cost-effectiveness analyses that use data from cluster randomized trials: a systematic review and checklist for critical appraisal. Med Decis Making 32: 209-20.
26. Gomez GB, Zwerling A, Bastos ML, Sweeney S, Foster N, Islam A, Trajman A, Grosskurth H, Sinanovic E, Knight G, White R, Wells W, Cobelens F, Vassall A,. 2015. In submission. Potentiona cost-effectiveness of four month regimenst for first line treatment of active tuberculosis: A cohort-based model comparison accross four countries.
27. Grieve R, Nixon R, Thompson SG, Normand C,. 2005. Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ 14: 185-96.
28. Hallett TB, Eaton JW,. 2013. A side door into care cascade for HIV-infected patients? J Acquir Immune Defic Syndr 63 (Suppl 2): S228-32.
29. Hansen KS, Grieve E, Mikhail A, Mayan I, Mohammed N, Anwar M, Baktash SH, Drake TL, Whitty CJ, Rowland MW, Leslie TJ,. 2015. Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan. Malar J 14: 217.
30. Harchut K, Standley C, Dobson A, Klaassen B, Rambaud-Althaus C, Althaus F, Nowak K,. 2013. Over-diagnosis of malaria by microscopy in the Kilombero Valley, Southern Tanzania: an evaluation of the utility and cost-effectiveness of rapid diagnostic tests. Malar J 12: 159.
31. Hawe P, Shiell A, Riley T,. 2004. Complex interventions: how "out of control" can a randomised controlled trial be? BMJ 328: 1561-3.
32. Langley I, Lin HH, Egwaga S, Doulla B, Ku CC, Murray M, Cohen T, Squire SB,. 2014. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. Lancet Glob Health 2: e581-91.
33. Laurence YV, Griffiths UK, Vassall A,. 2015. Costs to health services and the patient of treating tuberculosis: a systematic literature review. Pharmacoeconomics 33: 939-55.
34. Lemma H, San Sebastian M, Lofgren C, Barnabas G,. 2011. Cost-effectiveness of three malaria treatment strategies in rural Tigray, Ethiopia where both Plasmodium falciparum and Plasmodium vivax co-dominate. Cost Eff Resour Alloc 9: 2.
35. Levesque JF, Harris MF, Russell G,. 2013. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health 12: 18.
36. Lin HH, Langley I, Mwenda R, Doulla B, Egwaga S, Millington KA, Mann GH, Murray M, Squire SB, Cohen T,. 2011. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. Int J Tuberc Lung Dis 15: 996-1004.
37. Lubell Y, Hopkins H, Whitty CJ, Staedke SG, Mills A,. 2008a. An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria. Malar J 7: 21.
38. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya K, Whitty CJ, Mills A,. 2007. The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy. Am J Trop Med Hyg 77: 128-32.
39. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, Whitty CJ, Mills A,. 2008b. The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ 336: 202-5.
40. Ly AB, Tall A, Perry R, Baril L, Badiane A, Faye J, Rogier C, Toure A, Sokhna C, Trape JF, Michel R,. 2010. Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar J 9: 153.
41. Manca A, Willan AR,. 2006. 'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics 24: 1101-19.
42. Mangham-Jefferies L, Wiseman V, Achonduh OA, Drake TL, Cundill B, Onwujekwe O, Mbacham W,. 2014. Economic evaluation of a cluster randomized trial of interventions to improve health workers' practice in diagnosing and treating uncomplicated malaria in cameroon. Value Health 17: 783-91.
43. Mbacham WF, Mangham-Jefferies L, Cundill B, Achonduh OA, Chandler CI, Ambebila JN, Nkwescheu A, Forsah-Achu D, Ndiforchu V, Tchekountouo O, Akindeh-Nji M, Ongolo-Zogo P, Wiseman V,. 2014. Basic or enhanced clinician training to improve adherence to malaria treatment guidelines: a cluster-randomised trial in two areas of Cameroon. Lancet Glob Health 2: e346-58.
44. Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA,. 2012. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med 9 (11): e1001347.
45. Menzies NA, Cohen T, Murray M, Salomon JA,. 2015. Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. Lancet Infect Dis 15: 16-7.
46. Meyer-Rath G, Bistline K, Long L, Macleod W, Sanne I, Stevens W, Rosen S,. 2011. The incremental cost of introducing Xpert MTB/RIF into the South African National Tuberculosis Programme. Johannesburg: Health Economics and Epidemiology Research Office, Wits Health Consortium, University of the Witwatersrand (HE2RO).
47. Meyer-Rath G, Schnippel K, Long L, Macleod W, Sanne I, Stevens W, Pillay S, Pillay Y, Rosen S,. 2012. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One 7 (5): e36966.
48. Nasser SM, Cooke G, Kranzer K, Norris SL, Olliaro P, Ford N,. 2014. Strength of recommendations in WHO guidelines using GRADE was associated with uptake in national policy. J Clin Epidemiol 68 (6): 703-7.
49. Onwujekwe O, Mangham-Jefferies L, Cundill B, Alexander N, Langham J, Ibe O, Uzochukwu B, Wiseman V,. 2015. Effectiveness of provider and community interventions to improve treatment of uncomplicated malaria in Nigeria: a cluster randomized controlled trial. PLoS One 10 (8): e0133832.
50. Pretorius C, Glaziou P, Dodd PJ, White R, Houben R,. 2014a. Using the TIME model in spectrum to estimate tuberculosis-HIV incidence and mortality. AIDS 28 (Suppl 4): S477-87.
51. Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, Fraser C, Gopalappa C, Hallett TB, Salomon JA, Stover J, White RG, Dodd PJ,. 2014b. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS 28 (Suppl. 1): S25-34.
52. Rolland E, Checchi F, Pinoges L, Balkan S, Guthmann JP, Guerin PJ,. 2006. Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health 11: 398-408.
53. Rosas Aguirre AM, Llanos Zavalaga LF, Trelles De Belaunde M,. 2009. [Cost-effectiveness ratio of using rapid tests for malaria diagnosis in the Peruvian Amazon]. Rev Panam Salud Publica 25: 377-88.
54. Schwartlander B, Stover J, Hallett T, Atun R, Avila C, Gouws E, Bartos M, Ghys PD, Opuni M, Barr D, Alsallaq R, Bollinger L, De Freitas M, Garnett G, Holmes C, Legins K, Pillay Y, Stanciole AE, Mcclure C, Hirnschall G, Laga M, Padian N, Investment Framework Study G. 2011. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 377: 2031-41.
55. Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A,. 2004. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess 8 (49): iii-iv, 1-192.
56. Shiell A, Hawe P, Gold L,. 2008. Complex interventions or complex systems? Implications for health economic evaluation. BMJ 336: 1281-3.
57. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJ, Mills A,. 2008. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ 86: 101-10.
58. Terris-Prestholt F, Quaife M, Vickerman P,. 2016. Parameterising user uptake in economic evaluations: the role of discrete choice experiments. Health Economics, DOI: 10.1002/hec.3297.
59. Theron G, Peter J, Dowdy D, Langley I, Squire SB, Dheda K,. 2014a. Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? Lancet Infect Dis 14: 527-32.
60. Theron G, Pooran A, Peter J, Van Zyl-Smit R, Kumar Mishra H, Meldau R, Calligaro G, Allwood B, Sharma SK, Dawson R, Dheda K,. 2012. Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Eur Respir J 40: 161-8.
61. Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, Bara W, Mungofa S, Pai M, Hoelscher M, Dowdy D, Pym A, Mwaba P, Mason P, Peter J, Dheda K, Team T-N,. 2014b. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 383: 424-35.
62. Thiam S, Thior M, Faye B, Ndiop M, Diouf ML, Diouf MB, Diallo I, Fall FB, Ndiaye JL, Albertini A, Lee E, Jorgensen P, Gaye O, Bell D,. 2011. Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests. PLoS One 6 (4): e18419.
63. Uzochukwu BS, Obikeze EN, Onwujekwe OE, Onoka CA, Griffiths UK,. 2009. Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT. Malar J 8: 265.
64. Van't Hoog AH, Cobelens F, Vassall A, Van Kampen S, Dorman SE, Alland D, Ellner J,. 2013. Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis. PLoS One 8 (12): e82786.
65. Vassall A, Van Kampen S, Sohn H, Michael JS, John KR, Den Boon S, Davis JL, Whitelaw A, Nicol MP, Gler MT, Khaliqov A, Zamudio C, Perkins MD, Boehme CC, Cobelens F,. 2011. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 8 (11): e1001120.
66. Winfrey W, McKinnon R, Stover J,. 2011. Methods used in the Lives Saved Tool (LiST). BMC Public Health 11 (Suppl. 3): S32.
67. World Heatlh Organisation. 2012. WHO Handbook for Guideline Development, World Health Organisation: Geneva, Switzerland.
68. Yukich J, D'Acremont V, Kahama J, Swai N, Lengeler C,. 2010. Cost savings with rapid diagnostic tests for malaria in low-transmission areas: evidence from Dar es Salaam, Tanzania. Am J Trop Med Hyg 83: 61-8.
69. Zikusooka CM, Mcintyre D, Barnes KI,. 2008. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Malar J 7: 176.
70. Zurovac D, Larson BA, Skarbinski J, Slutsker L, Snow RW, Hamel MJ,. 2008. Modeling the financial and clinical implications of malaria rapid diagnostic tests in the case-management of older children and adults in Kenya. Am J Trop Med Hyg 78: 884-91.
71. Zwerling A, White RG, Vassall A, Cohen T, Dowdy DW, Houben RM,. 2014. Modeling of novel diagnostic strategies for active tuberculosis-a systematic review: current practices and recommendations. PLoS One 9 (10): e110558.